Sucampo's lubiprostone approved in Japan for constipation
This article was originally published in Scrip
Executive Summary
Sucampo Pharmaceuticals' Amitiza (lubiprostone) has become the first prescription drug to be approved in Japan for the treatment of chronic constipation, excluding that caused by organic diseases.